The North America C-Reactive Protein (CRP) rapid test market is witnessing steady expansion, driven by the increasing burden of chronic and infectious diseases, growing demand for point-of-care diagnostics, and advancements in rapid testing technologies. CRP rapid tests are widely used to detect inflammation and monitor conditions such as cardiovascular diseases, infections, and autoimmune disorders. The strong healthcare infrastructure across the U.S. and Canada, coupled with early adoption of innovative diagnostic solutions, positions North America as a leading regional market. Additionally, rising awareness regarding preventive healthcare and early disease detection continues to fuel market demand.

North America C-Reactive Protein Rapid Test Market Growth Outlook

The C-Reactive Protein Rapid Test Market Growth Outlook remains positive due to factors such as increased adoption of rapid diagnostic kits, technological advancements in immunoassay techniques, and a growing emphasis on decentralized healthcare solutions. C-Reactive Protein Rapid Test market is expected to register a CAGR of 6.29% from 2026 to 2034, with the market size expanding from US$ 1,095.91 Million in 2025 to US$ 1,898.00 Million by 2034. North America dominates the broader CRP testing market, accounting for over 40% of global revenue share, primarily due to advanced healthcare systems and high disease prevalence .

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00021650

Market Drivers and Key Trends

The rising incidence of cardiovascular diseases, diabetes, and inflammatory disorders is one of the primary drivers of the CRP rapid test market in North America. CRP is a key biomarker used for early detection and monitoring of these conditions, making rapid testing solutions highly valuable in clinical settings. Furthermore, the growing demand for point-of-care testing (POCT) has significantly accelerated the adoption of CRP rapid tests, as they provide quick results and enable faster clinical decision-making.

Technological advancements, such as high-sensitivity CRP (hs-CRP) assays and automated diagnostic platforms, are enhancing the accuracy and efficiency of rapid testing. Additionally, the shift toward personalized medicine and preventive healthcare is encouraging healthcare providers to adopt rapid diagnostic tools for early intervention. Government initiatives, favorable reimbursement policies, and increased healthcare spending further contribute to market growth in the region.

Market Segmentation Analysis

The North America CRP rapid test market is segmented based on type and end user. By type, the market includes immunoturbidimetric assays, ELISA, chemiluminescence immunoassays (CLIA), and others. Among these, immunoturbidimetric assays dominate the market due to their high accuracy and widespread adoption in clinical laboratories.

Based on end users, the market is categorized into hospitals, diagnostic laboratories, and others. Hospitals hold the largest market share, as they are primary centers for disease diagnosis and patient monitoring. However, diagnostic laboratories are expected to witness significant growth due to increased outsourcing of diagnostic services and advancements in laboratory technologies.

Regional Insights

North America continues to lead the CRP rapid test market due to its robust healthcare infrastructure, high adoption of advanced diagnostic technologies, and strong presence of key market players. The United States accounts for the largest share within the region, driven by high healthcare expenditure and increasing prevalence of chronic diseases. Canada is also emerging as a promising market, supported by government healthcare initiatives and rising awareness of early disease detection.

The region benefits from strong research and development activities, as well as continuous product innovation by leading companies. Additionally, the integration of digital health technologies and telemedicine is further enhancing the accessibility and efficiency of CRP rapid testing solutions.

Competitive Landscape and Top Players

The North America CRP rapid test market is highly competitive, with several global and regional players focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market presence.

Top Players:

• HORIBA Ltd.
• Thermo Fisher Scientific, Inc.
• F Hoffmann-La Roche Ltd.
• Quest Diagnostics
• Abbott
• Siemens Healthineers
• Danaher
• Ortho Clinical Diagnostics
• Laboratory Corporation of America Holdings
• Merck and Co., Inc.
• BIOTECHNE (R AND D SYSTEMS)
• ABCAM
• RANDOX LABORATORIES LTD
• LIFESPAN BIOSCIENCES, INC

Future Outlook

The future of the North America C-Reactive Protein rapid test market looks promising, with increasing demand for rapid and accurate diagnostic solutions. The ongoing shift toward decentralized healthcare and home-based testing is expected to create new growth opportunities for market players. Moreover, advancements in biotechnology and diagnostic platforms will continue to enhance test performance and expand application areas.

Related Report:

1) Robotic Nurse Assistant Market Size, Growth & Demand by 2034

2) Wearable Breast Pump Market Share, Growth & Forecast by 2034

3) Specimen Retrieval Bags Market Size, Trends & Growth by 2034

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish